MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
MDxHealth SA - Ordinary Shares (MDXH)
Company Research
Source: GlobeNewswire
Tissue-based test volumes increase by 36%, liquid-based test volumes by 24% Company raises 2024 revenue guidance to $87-89 million, representing 25% growth Pro-forma cash of $53.5 million Conference call and webcast today at 4:30pm ET IRVINE, CA – November 6, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced its financial results for the third quarter and nine-month period ended September 30, 2024. Michael K. McGarrity, CEO of mdxhealth, commented: “We generated another strong topline performance in the third quarter of 2024, with year-over-year revenue growth of 21%, or 27% when adjusted for a backlog of Select mdx revenues in Q3 of last year following the finalization of Medicare coverage. Demand for our comprehensive menu remains robust, and we have commercial and market access teams in place to drive sustainable growth. We also strengthened our balance sheet during the quarter, with pa
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDXH
News
- MDxHealth SA (NASDAQ: MDXH) had its price target lowered by analysts at Piper Sandler from $8.00 to $6.00. They now have an "overweight" rating on the stock.MarketBeat
- MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]Yahoo! Finance
- What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
- MDxHealth SA (NASDAQ: MDXH) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $7.00 price target on the stock.MarketBeat
- MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6GlobeNewswire
MDXH
Earnings
- 11/6/24 - Miss
MDXH
Sec Filings
- 11/14/24 - Form SC
- 11/6/24 - Form 6-K
- 10/29/24 - Form 6-K
- MDXH's page on the SEC website